Study on the impact of biofilm formation by <i>Candida albicans</i> in recurrent vulvovaginal candidiasis on drug susceptibility. [PDF]
Li S, Shen Z, Wang S, Peng Y, Qi W.
europepmc +1 more source
Economic burden of recurrent vulvovaginal candidiasis in Uganda: a cost-of-illness analysis. [PDF]
Jonani B, Bongomin F.
europepmc +1 more source
D-lactic acid inhibits Candida albicans associated with vulvovaginal candidiasis: in vitro and in vivo effects and underlying mechanisms. [PDF]
Xia T +5 more
europepmc +1 more source
Vulvovaginal Candidiasis Among American Indian and Alaska Native People, Indian Health Service, 2016-2022. [PDF]
Benedict K +4 more
europepmc +1 more source
Regulatory gaps in over-the-counter antifungal access for vulvovaginal candidiasis in Uganda: A policy analysis framework. [PDF]
Jonani B, Kwizera R.
europepmc +1 more source
Pathogenesis and Clinical Management of Vulvovaginal Candidiasis in Mexican Diabetic Patients: A Literature Review. [PDF]
Mondragón Rosas E +9 more
europepmc +1 more source
Standardizing Vulvovaginal candidiasis diagnosis in Uganda: A case for British Association for Sexual Health and HIV 2019 guidelines. [PDF]
Jonani B.
europepmc +1 more source
Vaginal Royal Jelly for Vulvovaginal Candidiasis Treatment: A Randomized Clinical Trial. [PDF]
Ramazany Chaleshtori M +8 more
europepmc +1 more source
Virulence factors, biofilm formation and antifungal resistance in Candida albicans from recurrent vulvovaginal candidiasis patients: a comparative study. [PDF]
Yan C, Zhang J, Yang Y, Zeng X, Xiao G.
europepmc +1 more source
Vulvovaginal candidiasis: knowledge, practices and occurrence among pregnant women receiving antenatal care in a teaching hospital, Ghana. [PDF]
Edziah FS +8 more
europepmc +1 more source

